Literature DB >> 194245

Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy.

W B Looney, J S Trefil, H A Hopkins, C J Kovacs, R Ritenour, J G Schaffner.   

Abstract

A therapeutic strategy for combined radiotherapy and chemotherapy of experimental solid tumors has been devised. More effective utilization of combined chemotherapy and radiotherapy may be realized clinically if comparable information is obtained in man. The overall treatment efficiency of successive courses of treatment has been determined by a method that defines tumor response quantitatively over an entire spectrum of tumor responses. The findings of this study have shown that an individual tumor that responds well to the first course of therapy will respond well to the second and third courses of combined modality therapy. Various solid tumors in different animal species have demonstrated variability of response to treatment, analogous to the many types of response found clinically.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194245      PMCID: PMC431057          DOI: 10.1073/pnas.74.5.1983

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

Review 1.  Solid tumor models for the assessment of different treatment modalities: II: rapid, intermediate, and slow growing transplantable rat hepatomas.

Authors:  W B Looney; A A Mayo; C J Kovacs; H A Hopkins; R Simon; H P Morris
Journal:  Life Sci       Date:  1976-02-15       Impact factor: 5.037

2.  Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.

Authors:  W B Looney; J S Trefil; J G Schaffner; C J Kovacs; H A Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

3.  Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.

Authors:  H A Hopkins; C J Kovacs; W B Looney; J A Wakefield
Journal:  Cancer Biochem Biophys       Date:  1976

4.  Changes in cellularity induced by radiation in a solid tumour.

Authors:  C J Kovacs; H A Hopkins; M J Evans; W B Looney
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1976-08

5.  Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A.

Authors:  C J Kovacs; H A Hopkins; R M Simon; W B Looney
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

6.  Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.

Authors:  W B Looney; J G Schaffner; J S Trefil; C J Kovacs; H A Hopkins
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

  6 in total
  4 in total

1.  Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.

Authors:  Mizuki Nishino; Satoshi Wakai; Tomoyuki Hida; Suzanne E Dahlberg; Masahiro Ozaki; Hiroto Hatabu; Hisashi Tachizaki; Bruce E Johnson
Journal:  Eur J Radiol       Date:  2018-10-23       Impact factor: 3.528

2.  Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.

Authors:  Mizuki Nishino; Suzanne E Dahlberg; Linnea E Fulton; Subba R Digumarthy; Hiroto Hatabu; Bruce E Johnson; Lecia V Sequist
Journal:  Acad Radiol       Date:  2016-01-08       Impact factor: 3.173

3.  Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.

Authors:  Mizuki Nishino; Suzanne E Dahlberg; Stephanie Cardarella; David M Jackman; Michael S Rabin; Nikhil H Ramaiya; Hiroto Hatabu; Pasi A Jänne; Bruce E Johnson
Journal:  Cancer       Date:  2013-08-06       Impact factor: 6.860

4.  Response kinetics of host and experimental solid tumour after adriamycin.

Authors:  H A Hopkins; W B Looney; K Teja; A S Hobson; M S MacLeod
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.